Amphastar Pharmaceuticals (AMPH) Operating Margin (2013 - 2026)

Amphastar Pharmaceuticals has reported Operating Margin for 14 years, with the latest figure at 21.6% in Q2 2026.

• On a quarterly basis, Operating Margin fell 258.0% year-over-year to 21.6% in Q2 2026; TTM through Jun 2026 was 15.66%, a 948.0% decrease from a year earlier, with the FY2025 full-year figure at 19.5%, down 856.0% from the prior year.
• Operating Margin was 21.6% for Q2 2026 at Amphastar Pharmaceuticals, up from 7.96% in the prior quarter.
• The five-year high for Operating Margin was 40.25% in Q3 2023, with the low at 7.96% in Q1 2026.
• Average Operating Margin over 5 years is 23.65%, with a median of 24.03% recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Operating Margin surged 2092 bps in 2023, then tumbled 1664 bps in 2025.
• Over 5 years, Operating Margin stood at 28.02% in 2022, then rose by 8 bps to 30.31% in 2023, then retreated by 20 bps to 24.2% in 2024, then slipped by 20 bps to 19.45% in 2025, then advanced by 11 bps to 21.6% in 2026.
• The last three Operating Margin figures came in at 21.6% (Q2 2026), 7.96% (Q1 2026), and 19.45% (Q4 2025), per Business Quant data.